Results 191 to 200 of about 577,742 (361)

Familial Patterns in Acute Lymphoblastic Leukemia: Lessons From Three Siblings. [PDF]

Clin Case Rep
Khanahmad A, Khazaee-Nasirabadi MH, Nikpour N, Khosravi M.   +3 more
europepmc   +1 more source

Molecular cloning of the common acute lymphoblastic leukemia antigen (CALLA) identifies a type II integral membrane protein.

, 1988
Margaret A. Shipp, Neil Richardson, Peter H. Sayre, Nick R. Brown, Emma L. Masteller, Linda K. Clayton, J Ritz, Ellis L. Reinherz   +7 more
openalex   +1 more source

Follow‐up of osteonecrosis in paediatric acute lymphoblastic leukaemia patients treated with the NOPHO ALL2008 protocol

British Journal of Haematology, EarlyView.
Summary Although osteonecrosis (ON) is a common sequel after childhood acute lymphoblastic leukaemia treatment and may cause debilitating symptoms, its prognosis remains underexplored. We describe the radiological evolution of ON lesions in a Finnish patient cohort treated according to the The Nordic Society of Paediatric Haematology and Oncology ...
Roosa Rokkanen, Henri Aarnivala, Sanna Huhtaniska, Sauli Palmu, Tytti Pokka, Tuuli Pöyhönen, Maria Suo‐Palosaari, Pauliina Utriainen, Liisa Järvelä, Riitta Niinimäki   +9 more
wiley   +1 more source

Thrombotic and hemorrhagic strokes complicating early therapy for childhood acute lymphoblastic leukemia

, 1980
John R. Priest, Norma K.C. Ramsay, Richard E. Latchaw, Lawrence A. Lockman, Duane K. Hasegawa, Thomas D. Coates, Peter F. Coccia, J. Roger Edson, Mark E. Nesbit, William Krivit   +9 more
openalex   +1 more source

Has early mortality following single‐unit unrelated cord blood transplantation improved in recent years? A nationwide registry data analysis from 2003 to 2022 in Japan

British Journal of Haematology, EarlyView.
The 100‐day non‐relapse mortality after single‐unit cord blood transplantation significantly declined from 19.6% (2003–2007) to 9.5% (2018–2022), while the 3‐year overall survival improved from 38.8% to 54.4%. Haematopoietic recovery rates improved steadily, with neutrophil engraftment reaching 89.6% and platelet engraftment 78.0% in the most recent ...
Takaaki Konuma, Junya Kanda, Naoyuki Uchida, Masatsugu Tanaka, Fumihiko Kimura, Hideki Nakasone, Yasufumi Uehara, Masahito Tokunaga, Masako Toyosaki, Shigesaburo Miyakoshi, Noriko Doki, Kazuya Ishiwata, Hikaru Kobayashi, Yasushi Onishi, Yasuji Kozai, Koji Kato, Fumihiko Ishimaru, Takahiro Fukuda, Yoshiko Atsuta, Satoshi Takahashi   +19 more
wiley   +1 more source

Lymphoblastic Leukemia With P2RY8::CRLF2 Rearrangement and High Hyperdiploidy. [PDF]

Cureus
Tsunoda Y, Fukushima H, Nanmoku T, Deguchi T, Takada H.   +4 more
europepmc   +1 more source

Comparison of central nervous system prophylaxis with cranial radiation and intrathecal methotrexate versus intrathecal methotrexate alone in acute lymphoblastic leukemia [PDF]

, 1983
FS Muriel, E Svarch, S Pavlovsky, M Eppinger-Helft, J Braier, Beatriz Iade Vergara, G Garay, R Kvicala, JM Divito, R Failace, Eduardo Dibar, E Jimenez   +11 more
openalex   +1 more source

Graft‐versus‐host disease is not associated with reduced incidence of relapse following haploidentical stem cell transplantation with post‐transplant cyclophosphamide for acute lymphoblastic leukaemia: A study on behalf of the Acute Leukaemia Working Party of European Society for Blood and Marrow Transplantation

British Journal of Haematology, EarlyView.
Summary The graft‐versus‐leukaemia effect (GVL) is closely associated with graft‐versus‐host disease (GVHD) after human leucocyte antigen (HLA)‐matched allogeneic stem‐cell transplantation (SCT) in acute lymphoblastic leukaemia (ALL). However, there are no data on this association following haploidentical SCT (haploSCT) with post‐transplant ...
Avichai Shimoni, Christophe Peczynski, Myriam Labopin, Alida Dominietto, Mariya Koc, Mutlu Arat, Johanna Tischer, Simona Sica, Zafer Gülbas, Gerard Socié, Didier Blaise, Pietro Pioltelli, Hakan Ozdogu, Jan Vydra, Fabio Ciceri, Arnon Nagler, Mohamad Mohty   +16 more
wiley   +1 more source

Adipocytes Impair Mitoxantrone Cytotoxicity Against Acute Lymphoblastic Leukemia. [PDF]

EJHaem
Cohen M, Orgel E, Nevarez-Mejia J, Chen T, Neely M, Louie S, Mittelman SD.   +6 more
europepmc   +1 more source

Biochemical and Immunological Properties of Human Terminal Deoxynucleotidyl Transferase Purified from Blasts of Acute Lymphoblastic and Chronic Myelogenous Leukemia [PDF]

, 1981
Martin R. Deibel, Mary Sue Colemán, Karen Acree, John J. Hutton   +3 more
openalex   +1 more source